Mi Young Ko

Title: Mi Young Ko: Innovator in Pharmaceutical Development

Introduction

Mi Young Ko is a notable inventor based in Suwon-si, South Korea. She has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that inhibit cancer cell growth. With a total of three patents to her name, her work reflects a commitment to advancing medical science.

Latest Patents

One of her latest patents is an amide derivative for inhibiting the growth of cancer cells. This invention provides a novel amide derivative of formula (I) and a pharmaceutically acceptable salt thereof, along with a pharmaceutical composition comprising the same as an active ingredient. Another significant patent involves the method of preparing clopidogrel and the intermediates used therein. This method allows for the optically pure clopidogrel to be prepared in high yield by optically resolving a racemic form of the compound of formula (II) using an optically active amine.

Career Highlights

Throughout her career, Mi Young Ko has worked with prominent companies in the pharmaceutical industry, including Hanmi Pharm. Co., Ltd. and Hanmi Holdings Co., Ltd. Her expertise in drug development has positioned her as a key figure in her field.

Collaborations

Mi Young Ko has collaborated with several professionals, including Eun Sook Kim and Hee Cheol Kim. These collaborations have further enhanced her research and development efforts.

Conclusion

Mi Young Ko's innovative work in pharmaceuticals demonstrates her dedication to improving healthcare through scientific advancements. Her patents reflect her significant contributions to cancer treatment and drug development.